Investing.com - Financial Markets Worldwide

Beijing Biostar Pharmaceuticals Co Ltd (2563)

Hong Kong
Currency in HKD
8.76
+0.06(+0.69%)
Closed·
2563 Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
2563 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
8.478.82
52 wk Range
4.2839.50
Key Statistics
Edit
Bid/Ask
8.76 / 8.76
Prev. Close
8.7
Open
8.82
Day's Range
8.47-8.82
52 wk Range
4.28-39.5
Volume
458.8K
Average Volume (3m)
667.35K
1-Year Change
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
2563 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 13
Impressive gross profit margins
Unlock InvestingPro

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Beijing Biostar Pharmaceuticals Co Ltd Company Profile

Beijing Biostar Pharmaceuticals Co., Ltd., a synthetic biology-driven biopharmaceutical company, engages in the research, development, manufacture, and commercialization of oncology products in the People’s Republic of China. The company develops Utidelone injection, a microtubule inhibitor for the treatment of advanced and neoadjuvant breast cancer, advanced non-small cell lung cancer, gastric and esophageal cancer, brain metastasis, solid tumors, and glioblastoma. It is also involved in the development of Utidelone capsule that is in Phase II/III clinical trials; Utidelone nanoformulation; and Utidelone antibody drug conjugate, as well as other active pharmaceutical ingredients, such as BG22, BG18, and BG44 in early development stages. The company develops its pharmaceutical products through its technology platforms, including combinatorial biosynthesis, microbial fermentation production, and microbial drug formulation development platforms. In addition, it provides medical consultation services. Beijing Biostar Pharmaceuticals Co., Ltd. was incorporated in 2002 and is headquartered in Beijing, China.

Industry
Pharmaceuticals
Sector
Healthcare
Employees
147
Market
Hong Kong

Compare 2563 to Peers and Sector

Metrics to compare
2563
Peers
Sector
Relationship
P/E Ratio
−12.1x−16.2x−0.6x
PEG Ratio
−0.490.170.00
Price/Book
-6.3x2.6x
Price / LTM Sales
24.3x20.0x3.3x
Upside (Analyst Target)
320.0%−12.9%39.1%
Fair Value Upside
Unlock−18.9%4.5%Unlock

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
a
a
Unlock
Last 90 days

2563 Income Statement

FAQ

What Stock Exchange Does Beijing Biostar Pharmaceuticals Trade On?

Beijing Biostar Pharmaceuticals is listed and trades on the Hong Kong Stock Exchange stock exchange.

What Is the Stock Symbol for Beijing Biostar Pharmaceuticals?

The stock symbol for Beijing Biostar Pharmaceuticals is "2563."

What Is the Beijing Biostar Pharmaceuticals Market Cap?

As of today, Beijing Biostar Pharmaceuticals market cap is 1.84B.

What Is Beijing Biostar Pharmaceuticals's Earnings Per Share (TTM)?

The Beijing Biostar Pharmaceuticals EPS (TTM) is -0.41.

From a Technical Analysis Perspective, Is 2563 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Beijing Biostar Pharmaceuticals Stock Split?

Beijing Biostar Pharmaceuticals has split 0 times.

How Many Employees Does Beijing Biostar Pharmaceuticals Have?

Beijing Biostar Pharmaceuticals has 147 employees.

What is the current trading status of Beijing Biostar Pharmaceuticals (2563)?

As of 19 Aug 2025, Beijing Biostar Pharmaceuticals (2563) is trading at a price of 8.76, with a previous close of 8.70. The stock has fluctuated within a day range of 8.47 to 8.82, while its 52-week range spans from 4.28 to 39.50.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.